Topiramate, an old drug for a new goal, weight reduction in obese patients, cardiometabolic implications
6 octubre, 2014Topiramate Sabán-Ruiz, J. Alonso-Pacho, A. Fabregate-Fuente, M. De la Puerta González-Quevedo, C. Fabregate-Fuente, R. Tello-Blasco, S. Guerri, A. Topiramate. Anti Obesity Drug Discovery and Development, suppl: (in ...Oxidase Inhibitor Febuxostat as a Novel Agent Postulates to Act Against Vascular Inflammation
6 octubre, 2013Oxidase Inhibitor Febuxostat as a Novel Agent Postulates to Act Against Vascular Inflammation Sabán-Ruiz, J. Alonso-Pacho, A. Fabregate-Fuente, M. and De la Puerta González-Quevedo, C. Xantine Anti-Inflammatory ...Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy.
28 febrero, 2008Lights and shades in the application of new guidelines for the management of type 2 diabetes mellitus. Practical advice about combined therapy and insulin therapy. Sánchez ...